Article info

PDF

Response to e-letter: ‘Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment’ by Lee

Authors

  1. Correspondence to Dr Yuko Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan; ykaneko{at}z6.keio.jp
View Full Text

Citation

Kaneko Y, Kameda H, Ikeda K, et al
Response to e-letter: ‘Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment’ by Lee

Publication history

  • Received October 29, 2018
  • Accepted November 1, 2018
  • First published November 10, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.